Matches in SemOpenAlex for { <https://semopenalex.org/work/W1562849145> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W1562849145 abstract "Non-small-cell lung cancer (NSCLC), accounts for approximately 80% of all lung tumors, that are a leading cause of cancer-related mortality in the world. Several protocols of monotherapy have been attempted with some success in a limited number and selected cases with several delusion and even failures. Combination therapy, may present some advantages and should be considered as a potentially promising approach. Although it has been proposed in certain conditions, yet it has not fully exploited. We have conducted an in vitro study on two non small cell lung carcinoma cell lines, namely A549 and H1299, that differ for the status of p53 protein (wid type and null respectively). We proposed a therapeutic approach based on the combination of anti EGFR drug (Gefitinib) and PDT (ALA-PDT). The combination is potentially efficient since the drug and PDT appear to target different cell growth pathways. The occurrence of simultaneous damages to different sites may improve the efficiency in killing the target cells. Gefitinib, is a synthetic EGF receptor inhibitor that blocks EGFR signal transduction pathways, responsible of the promotion of cancer cell proliferation. Photodynamic therapy (PDT) is a cancer treatment whose principal cytotoxicity is mediated by the production of reactive oxygen species that efficiently damage sub-cellular components. We demonstrated that specific combinations of Gefitinib and PDT treatment exert synergistic effect on cell growth inhibition of A549 and H1299 cells, and above all it strongly deranges the mitochondrial activity and cell proliferation. Interesting enough, such combinations contained Gefitinib at concentrations below the canonical effective value, so that the possible noxious side effects associated with the drug can be minimized. Having analyzed several molecular pathways upon individual and combined treatments, we observed that the two cell lines respond not identically at molecular levels especially as cell cycle and nuclear involvement are concerned. In particular PDT treatment induced S-phase block in H1299 and DNA damage. The latter observation was strengthened by the activation of damage sensor-proteins (ATM, ATR) plus the recruitment of histone H2AX. A549 cells did not perform similarly. Tentatively, this different behaviuor can be ascribed to the different status of the p53 protein in the two cell lines. In contrast, the behaviour of NF-B pathway, does not significantly differ in both cell lines. In fact the activation of NF-B transcription factor activity did not change following treatment with Gefitinib, was slight reduced following PDT, while in combined conditions a significant reduction in NF-B was observed. This decrease was determined by the the PDT-mediated inhibition of the proteasome, another recognized target in cancer therapy. In our systems we observed that the proteasome inhibition was primarily caused by PDT treatment, but it was efficiently sustained by Gefitinib. This fact explains the efficiency of the combined therapy." @default.
- W1562849145 created "2016-06-24" @default.
- W1562849145 creator A5015247344 @default.
- W1562849145 date "2010-11-30" @default.
- W1562849145 modified "2023-09-24" @default.
- W1562849145 title "Combined therapy with delta-aminolevulinic acid/photodynamic therapy and EGF-R inhibitor Gefitinib in non small cell lung carcinoma cell lines" @default.
- W1562849145 hasPublicationYear "2010" @default.
- W1562849145 type Work @default.
- W1562849145 sameAs 1562849145 @default.
- W1562849145 citedByCount "0" @default.
- W1562849145 crossrefType "journal-article" @default.
- W1562849145 hasAuthorship W1562849145A5015247344 @default.
- W1562849145 hasConcept C109316439 @default.
- W1562849145 hasConcept C121608353 @default.
- W1562849145 hasConcept C126322002 @default.
- W1562849145 hasConcept C143998085 @default.
- W1562849145 hasConcept C1491633281 @default.
- W1562849145 hasConcept C178790620 @default.
- W1562849145 hasConcept C185592680 @default.
- W1562849145 hasConcept C202751555 @default.
- W1562849145 hasConcept C2776256026 @default.
- W1562849145 hasConcept C2776999253 @default.
- W1562849145 hasConcept C2779438470 @default.
- W1562849145 hasConcept C2780580887 @default.
- W1562849145 hasConcept C2781230642 @default.
- W1562849145 hasConcept C2781323092 @default.
- W1562849145 hasConcept C502942594 @default.
- W1562849145 hasConcept C55493867 @default.
- W1562849145 hasConcept C62112901 @default.
- W1562849145 hasConcept C71924100 @default.
- W1562849145 hasConcept C86803240 @default.
- W1562849145 hasConcept C98274493 @default.
- W1562849145 hasConceptScore W1562849145C109316439 @default.
- W1562849145 hasConceptScore W1562849145C121608353 @default.
- W1562849145 hasConceptScore W1562849145C126322002 @default.
- W1562849145 hasConceptScore W1562849145C143998085 @default.
- W1562849145 hasConceptScore W1562849145C1491633281 @default.
- W1562849145 hasConceptScore W1562849145C178790620 @default.
- W1562849145 hasConceptScore W1562849145C185592680 @default.
- W1562849145 hasConceptScore W1562849145C202751555 @default.
- W1562849145 hasConceptScore W1562849145C2776256026 @default.
- W1562849145 hasConceptScore W1562849145C2776999253 @default.
- W1562849145 hasConceptScore W1562849145C2779438470 @default.
- W1562849145 hasConceptScore W1562849145C2780580887 @default.
- W1562849145 hasConceptScore W1562849145C2781230642 @default.
- W1562849145 hasConceptScore W1562849145C2781323092 @default.
- W1562849145 hasConceptScore W1562849145C502942594 @default.
- W1562849145 hasConceptScore W1562849145C55493867 @default.
- W1562849145 hasConceptScore W1562849145C62112901 @default.
- W1562849145 hasConceptScore W1562849145C71924100 @default.
- W1562849145 hasConceptScore W1562849145C86803240 @default.
- W1562849145 hasConceptScore W1562849145C98274493 @default.
- W1562849145 hasLocation W15628491451 @default.
- W1562849145 hasOpenAccess W1562849145 @default.
- W1562849145 hasPrimaryLocation W15628491451 @default.
- W1562849145 hasRelatedWork W1512055490 @default.
- W1562849145 hasRelatedWork W1687624338 @default.
- W1562849145 hasRelatedWork W1951741034 @default.
- W1562849145 hasRelatedWork W2040246237 @default.
- W1562849145 hasRelatedWork W2041963587 @default.
- W1562849145 hasRelatedWork W2061603582 @default.
- W1562849145 hasRelatedWork W2062887013 @default.
- W1562849145 hasRelatedWork W2095912523 @default.
- W1562849145 hasRelatedWork W2114621192 @default.
- W1562849145 hasRelatedWork W2126052870 @default.
- W1562849145 hasRelatedWork W2147753291 @default.
- W1562849145 hasRelatedWork W2148136524 @default.
- W1562849145 hasRelatedWork W2167785152 @default.
- W1562849145 hasRelatedWork W2303936412 @default.
- W1562849145 hasRelatedWork W2327106147 @default.
- W1562849145 hasRelatedWork W2393752689 @default.
- W1562849145 hasRelatedWork W2467901334 @default.
- W1562849145 hasRelatedWork W2935962579 @default.
- W1562849145 hasRelatedWork W2981036811 @default.
- W1562849145 hasRelatedWork W3000634367 @default.
- W1562849145 isParatext "false" @default.
- W1562849145 isRetracted "false" @default.
- W1562849145 magId "1562849145" @default.
- W1562849145 workType "article" @default.